1YVL - JenaLib

Asymmetric Unit (27, 54)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_034521	I	30	T	STAT1_HUMAN	Polymorphism	34255470	A B	I	30 1030	T
02	UniProt	VAR_065934	D	165	G	STAT1_HUMAN	Disease (IMD31C)	387906764	A B	D	165 1165	G
03	UniProt	VAR_065935	D	165	H	STAT1_HUMAN	Disease (IMD31C)	387906767	A B	D	165 1165	H
04	UniProt	VAR_065936	Y	170	N	STAT1_HUMAN	Disease (IMD31C)	387906766	A B	Y	170 1170	N
05	UniProt	VAR_065937	C	174	R	STAT1_HUMAN	Disease (IMD31C)	387906763	A B	C	174 1174	R
06	UniProt	VAR_075494	N	179	K	STAT1_HUMAN	Disease (IMD31C)	587777628	A B	N	179 1179	K
07	UniProt	VAR_065815	K	201	N	STAT1_HUMAN	Disease (IMD31B)	587776870	A B	K	201 1201	N
08	UniProt	VAR_065938	M	202	I	STAT1_HUMAN	Disease (IMD31C)	---	A B	M	202 1202	I
09	UniProt	VAR_065939	M	202	V	STAT1_HUMAN	Disease (IMD31C)	387906762	A B	M	202 1202	V
10	UniProt	VAR_065940	A	267	V	STAT1_HUMAN	Disease (IMD31C)	387906759	A B	A	267 1267	V
11	UniProt	VAR_065941	Q	271	P	STAT1_HUMAN	Disease (IMD31C)	387906768	A B	Q	271 1271	P
12	UniProt	VAR_065942	R	274	Q	STAT1_HUMAN	Disease (IMD31C)	387906760	A B	R	274 1274	Q
13	UniProt	VAR_065943	R	274	W	STAT1_HUMAN	Disease (IMD31C)	387906758	A B	R	274 1274	W
14	UniProt	VAR_075495	K	278	E	STAT1_HUMAN	Disease (IMD31C)	863223398	A B	K	278 1278	E
15	UniProt	VAR_075496	Q	285	R	STAT1_HUMAN	Disease (IMD31C)	587777629	A B	Q	285 1285	R
16	UniProt	VAR_065944	K	286	I	STAT1_HUMAN	Disease (IMD31C)	387906761	A B	K	286 1286	I
17	UniProt	VAR_065945	T	288	A	STAT1_HUMAN	Disease (IMD31C)	387906765	A B	T	288 1288	A
18	UniProt	VAR_075497	K	298	N	STAT1_HUMAN	Disease (IMD31C)	---	A B	K	298 1298	N
19	UniProt	VAR_065816	E	320	Q	STAT1_HUMAN	Disease (IMD31A)	137852680	A B	E	320 1320	Q
20	UniProt	VAR_075498	G	384	D	STAT1_HUMAN	Disease (IMD31C)	796065052	A B	G	384 1384	D
21	UniProt	VAR_075499	T	385	M	STAT1_HUMAN	Disease (IMD31C)	587777630	A B	T	385 1385	M
22	UniProt	VAR_065817	Q	463	H	STAT1_HUMAN	Disease (IMD31A)	137852679	A B	Q	463 1463	H
23	UniProt	VAR_036001	P	491	A	STAT1_HUMAN	Unclassified	---	A B	P	491 1491	A
24	CancerSNP	VAR_STAT1_HUMAN_CCDS2309_1_01 *	P	491	A	STAT1_HUMAN	Disease (Breast cancer)	---	A B	P	491 1491	A
25	UniProt	VAR_018265	L	600	P	STAT1_HUMAN	Disease (IMD31B)	137852678	A B	L	600 1600	P
26	UniProt	VAR_068713	K	637	E	STAT1_HUMAN	Disease (IMD31A)	587777705	A B	K	637 1637	E
27	UniProt	VAR_068714	K	673	R	STAT1_HUMAN	Disease (IMD31A)	587777704	A B	K	673 1673	R
	* ID not provided by source

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 1 (27, 27)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_034521	I	30	T	STAT1_HUMAN	Polymorphism	34255470	A A	I	30 1030	T
02	UniProt	VAR_065934	D	165	G	STAT1_HUMAN	Disease (IMD31C)	387906764	A A	D	165 1165	G
03	UniProt	VAR_065935	D	165	H	STAT1_HUMAN	Disease (IMD31C)	387906767	A A	D	165 1165	H
04	UniProt	VAR_065936	Y	170	N	STAT1_HUMAN	Disease (IMD31C)	387906766	A A	Y	170 1170	N
05	UniProt	VAR_065937	C	174	R	STAT1_HUMAN	Disease (IMD31C)	387906763	A A	C	174 1174	R
06	UniProt	VAR_075494	N	179	K	STAT1_HUMAN	Disease (IMD31C)	587777628	A A	N	179 1179	K
07	UniProt	VAR_065815	K	201	N	STAT1_HUMAN	Disease (IMD31B)	587776870	A A	K	201 1201	N
08	UniProt	VAR_065938	M	202	I	STAT1_HUMAN	Disease (IMD31C)	---	A A	M	202 1202	I
09	UniProt	VAR_065939	M	202	V	STAT1_HUMAN	Disease (IMD31C)	387906762	A A	M	202 1202	V
10	UniProt	VAR_065940	A	267	V	STAT1_HUMAN	Disease (IMD31C)	387906759	A A	A	267 1267	V
11	UniProt	VAR_065941	Q	271	P	STAT1_HUMAN	Disease (IMD31C)	387906768	A A	Q	271 1271	P
12	UniProt	VAR_065942	R	274	Q	STAT1_HUMAN	Disease (IMD31C)	387906760	A A	R	274 1274	Q
13	UniProt	VAR_065943	R	274	W	STAT1_HUMAN	Disease (IMD31C)	387906758	A A	R	274 1274	W
14	UniProt	VAR_075495	K	278	E	STAT1_HUMAN	Disease (IMD31C)	863223398	A A	K	278 1278	E
15	UniProt	VAR_075496	Q	285	R	STAT1_HUMAN	Disease (IMD31C)	587777629	A A	Q	285 1285	R
16	UniProt	VAR_065944	K	286	I	STAT1_HUMAN	Disease (IMD31C)	387906761	A A	K	286 1286	I
17	UniProt	VAR_065945	T	288	A	STAT1_HUMAN	Disease (IMD31C)	387906765	A A	T	288 1288	A
18	UniProt	VAR_075497	K	298	N	STAT1_HUMAN	Disease (IMD31C)	---	A A	K	298 1298	N
19	UniProt	VAR_065816	E	320	Q	STAT1_HUMAN	Disease (IMD31A)	137852680	A A	E	320 1320	Q
20	UniProt	VAR_075498	G	384	D	STAT1_HUMAN	Disease (IMD31C)	796065052	A A	G	384 1384	D
21	UniProt	VAR_075499	T	385	M	STAT1_HUMAN	Disease (IMD31C)	587777630	A A	T	385 1385	M
22	UniProt	VAR_065817	Q	463	H	STAT1_HUMAN	Disease (IMD31A)	137852679	A A	Q	463 1463	H
23	UniProt	VAR_036001	P	491	A	STAT1_HUMAN	Unclassified	---	A A	P	491 1491	A
24	CancerSNP	VAR_STAT1_HUMAN_CCDS2309_1_01 *	P	491	A	STAT1_HUMAN	Disease (Breast cancer)	---	A A	P	491 1491	A
25	UniProt	VAR_018265	L	600	P	STAT1_HUMAN	Disease (IMD31B)	137852678	A A	L	600 1600	P
26	UniProt	VAR_068713	K	637	E	STAT1_HUMAN	Disease (IMD31A)	587777705	A A	K	637 1637	E
27	UniProt	VAR_068714	K	673	R	STAT1_HUMAN	Disease (IMD31A)	587777704	A A	K	673 1673	R
	* ID not provided by source

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 2 (27, 27)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_034521	I	30	T	STAT1_HUMAN	Polymorphism	34255470	A B	I	30 1030	T
02	UniProt	VAR_065934	D	165	G	STAT1_HUMAN	Disease (IMD31C)	387906764	A B	D	165 1165	G
03	UniProt	VAR_065935	D	165	H	STAT1_HUMAN	Disease (IMD31C)	387906767	A B	D	165 1165	H
04	UniProt	VAR_065936	Y	170	N	STAT1_HUMAN	Disease (IMD31C)	387906766	A B	Y	170 1170	N
05	UniProt	VAR_065937	C	174	R	STAT1_HUMAN	Disease (IMD31C)	387906763	A B	C	174 1174	R
06	UniProt	VAR_075494	N	179	K	STAT1_HUMAN	Disease (IMD31C)	587777628	A B	N	179 1179	K
07	UniProt	VAR_065815	K	201	N	STAT1_HUMAN	Disease (IMD31B)	587776870	A B	K	201 1201	N
08	UniProt	VAR_065938	M	202	I	STAT1_HUMAN	Disease (IMD31C)	---	A B	M	202 1202	I
09	UniProt	VAR_065939	M	202	V	STAT1_HUMAN	Disease (IMD31C)	387906762	A B	M	202 1202	V
10	UniProt	VAR_065940	A	267	V	STAT1_HUMAN	Disease (IMD31C)	387906759	A B	A	267 1267	V
11	UniProt	VAR_065941	Q	271	P	STAT1_HUMAN	Disease (IMD31C)	387906768	A B	Q	271 1271	P
12	UniProt	VAR_065942	R	274	Q	STAT1_HUMAN	Disease (IMD31C)	387906760	A B	R	274 1274	Q
13	UniProt	VAR_065943	R	274	W	STAT1_HUMAN	Disease (IMD31C)	387906758	A B	R	274 1274	W
14	UniProt	VAR_075495	K	278	E	STAT1_HUMAN	Disease (IMD31C)	863223398	A B	K	278 1278	E
15	UniProt	VAR_075496	Q	285	R	STAT1_HUMAN	Disease (IMD31C)	587777629	A B	Q	285 1285	R
16	UniProt	VAR_065944	K	286	I	STAT1_HUMAN	Disease (IMD31C)	387906761	A B	K	286 1286	I
17	UniProt	VAR_065945	T	288	A	STAT1_HUMAN	Disease (IMD31C)	387906765	A B	T	288 1288	A
18	UniProt	VAR_075497	K	298	N	STAT1_HUMAN	Disease (IMD31C)	---	A B	K	298 1298	N
19	UniProt	VAR_065816	E	320	Q	STAT1_HUMAN	Disease (IMD31A)	137852680	A B	E	320 1320	Q
20	UniProt	VAR_075498	G	384	D	STAT1_HUMAN	Disease (IMD31C)	796065052	A B	G	384 1384	D
21	UniProt	VAR_075499	T	385	M	STAT1_HUMAN	Disease (IMD31C)	587777630	A B	T	385 1385	M
22	UniProt	VAR_065817	Q	463	H	STAT1_HUMAN	Disease (IMD31A)	137852679	A B	Q	463 1463	H
23	UniProt	VAR_036001	P	491	A	STAT1_HUMAN	Unclassified	---	A B	P	491 1491	A
24	CancerSNP	VAR_STAT1_HUMAN_CCDS2309_1_01 *	P	491	A	STAT1_HUMAN	Disease (Breast cancer)	---	A B	P	491 1491	A
25	UniProt	VAR_018265	L	600	P	STAT1_HUMAN	Disease (IMD31B)	137852678	A B	L	600 1600	P
26	UniProt	VAR_068713	K	637	E	STAT1_HUMAN	Disease (IMD31A)	587777705	A B	K	637 1637	E
27	UniProt	VAR_068714	K	673	R	STAT1_HUMAN	Disease (IMD31A)	587777704	A B	K	673 1673	R
	* ID not provided by source

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 3 (27, 108)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_034521	I	30	T	STAT1_HUMAN	Polymorphism	34255470	A A/B	I	30 1030	T
02	UniProt	VAR_065934	D	165	G	STAT1_HUMAN	Disease (IMD31C)	387906764	A A/B	D	165 1165	G
03	UniProt	VAR_065935	D	165	H	STAT1_HUMAN	Disease (IMD31C)	387906767	A A/B	D	165 1165	H
04	UniProt	VAR_065936	Y	170	N	STAT1_HUMAN	Disease (IMD31C)	387906766	A A/B	Y	170 1170	N
05	UniProt	VAR_065937	C	174	R	STAT1_HUMAN	Disease (IMD31C)	387906763	A A/B	C	174 1174	R
06	UniProt	VAR_075494	N	179	K	STAT1_HUMAN	Disease (IMD31C)	587777628	A A/B	N	179 1179	K
07	UniProt	VAR_065815	K	201	N	STAT1_HUMAN	Disease (IMD31B)	587776870	A A/B	K	201 1201	N
08	UniProt	VAR_065938	M	202	I	STAT1_HUMAN	Disease (IMD31C)	---	A A/B	M	202 1202	I
09	UniProt	VAR_065939	M	202	V	STAT1_HUMAN	Disease (IMD31C)	387906762	A A/B	M	202 1202	V
10	UniProt	VAR_065940	A	267	V	STAT1_HUMAN	Disease (IMD31C)	387906759	A A/B	A	267 1267	V
11	UniProt	VAR_065941	Q	271	P	STAT1_HUMAN	Disease (IMD31C)	387906768	A A/B	Q	271 1271	P
12	UniProt	VAR_065942	R	274	Q	STAT1_HUMAN	Disease (IMD31C)	387906760	A A/B	R	274 1274	Q
13	UniProt	VAR_065943	R	274	W	STAT1_HUMAN	Disease (IMD31C)	387906758	A A/B	R	274 1274	W
14	UniProt	VAR_075495	K	278	E	STAT1_HUMAN	Disease (IMD31C)	863223398	A A/B	K	278 1278	E
15	UniProt	VAR_075496	Q	285	R	STAT1_HUMAN	Disease (IMD31C)	587777629	A A/B	Q	285 1285	R
16	UniProt	VAR_065944	K	286	I	STAT1_HUMAN	Disease (IMD31C)	387906761	A A/B	K	286 1286	I
17	UniProt	VAR_065945	T	288	A	STAT1_HUMAN	Disease (IMD31C)	387906765	A A/B	T	288 1288	A
18	UniProt	VAR_075497	K	298	N	STAT1_HUMAN	Disease (IMD31C)	---	A A/B	K	298 1298	N
19	UniProt	VAR_065816	E	320	Q	STAT1_HUMAN	Disease (IMD31A)	137852680	A A/B	E	320 1320	Q
20	UniProt	VAR_075498	G	384	D	STAT1_HUMAN	Disease (IMD31C)	796065052	A A/B	G	384 1384	D
21	UniProt	VAR_075499	T	385	M	STAT1_HUMAN	Disease (IMD31C)	587777630	A A/B	T	385 1385	M
22	UniProt	VAR_065817	Q	463	H	STAT1_HUMAN	Disease (IMD31A)	137852679	A A/B	Q	463 1463	H
23	UniProt	VAR_036001	P	491	A	STAT1_HUMAN	Unclassified	---	A A/B	P	491 1491	A
24	CancerSNP	VAR_STAT1_HUMAN_CCDS2309_1_01 *	P	491	A	STAT1_HUMAN	Disease (Breast cancer)	---	A A/B	P	491 1491	A
25	UniProt	VAR_018265	L	600	P	STAT1_HUMAN	Disease (IMD31B)	137852678	A A/B	L	600 1600	P
26	UniProt	VAR_068713	K	637	E	STAT1_HUMAN	Disease (IMD31A)	587777705	A A/B	K	637 1637	E
27	UniProt	VAR_068714	K	673	R	STAT1_HUMAN	Disease (IMD31A)	587777704	A A/B	K	673 1673	R
	* ID not provided by source

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 4 (27, 54)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_034521	I	30	T	STAT1_HUMAN	Polymorphism	34255470	A A/B	I	30 1030	T
02	UniProt	VAR_065934	D	165	G	STAT1_HUMAN	Disease (IMD31C)	387906764	A A/B	D	165 1165	G
03	UniProt	VAR_065935	D	165	H	STAT1_HUMAN	Disease (IMD31C)	387906767	A A/B	D	165 1165	H
04	UniProt	VAR_065936	Y	170	N	STAT1_HUMAN	Disease (IMD31C)	387906766	A A/B	Y	170 1170	N
05	UniProt	VAR_065937	C	174	R	STAT1_HUMAN	Disease (IMD31C)	387906763	A A/B	C	174 1174	R
06	UniProt	VAR_075494	N	179	K	STAT1_HUMAN	Disease (IMD31C)	587777628	A A/B	N	179 1179	K
07	UniProt	VAR_065815	K	201	N	STAT1_HUMAN	Disease (IMD31B)	587776870	A A/B	K	201 1201	N
08	UniProt	VAR_065938	M	202	I	STAT1_HUMAN	Disease (IMD31C)	---	A A/B	M	202 1202	I
09	UniProt	VAR_065939	M	202	V	STAT1_HUMAN	Disease (IMD31C)	387906762	A A/B	M	202 1202	V
10	UniProt	VAR_065940	A	267	V	STAT1_HUMAN	Disease (IMD31C)	387906759	A A/B	A	267 1267	V
11	UniProt	VAR_065941	Q	271	P	STAT1_HUMAN	Disease (IMD31C)	387906768	A A/B	Q	271 1271	P
12	UniProt	VAR_065942	R	274	Q	STAT1_HUMAN	Disease (IMD31C)	387906760	A A/B	R	274 1274	Q
13	UniProt	VAR_065943	R	274	W	STAT1_HUMAN	Disease (IMD31C)	387906758	A A/B	R	274 1274	W
14	UniProt	VAR_075495	K	278	E	STAT1_HUMAN	Disease (IMD31C)	863223398	A A/B	K	278 1278	E
15	UniProt	VAR_075496	Q	285	R	STAT1_HUMAN	Disease (IMD31C)	587777629	A A/B	Q	285 1285	R
16	UniProt	VAR_065944	K	286	I	STAT1_HUMAN	Disease (IMD31C)	387906761	A A/B	K	286 1286	I
17	UniProt	VAR_065945	T	288	A	STAT1_HUMAN	Disease (IMD31C)	387906765	A A/B	T	288 1288	A
18	UniProt	VAR_075497	K	298	N	STAT1_HUMAN	Disease (IMD31C)	---	A A/B	K	298 1298	N
19	UniProt	VAR_065816	E	320	Q	STAT1_HUMAN	Disease (IMD31A)	137852680	A A/B	E	320 1320	Q
20	UniProt	VAR_075498	G	384	D	STAT1_HUMAN	Disease (IMD31C)	796065052	A A/B	G	384 1384	D
21	UniProt	VAR_075499	T	385	M	STAT1_HUMAN	Disease (IMD31C)	587777630	A A/B	T	385 1385	M
22	UniProt	VAR_065817	Q	463	H	STAT1_HUMAN	Disease (IMD31A)	137852679	A A/B	Q	463 1463	H
23	UniProt	VAR_036001	P	491	A	STAT1_HUMAN	Unclassified	---	A A/B	P	491 1491	A
24	CancerSNP	VAR_STAT1_HUMAN_CCDS2309_1_01 *	P	491	A	STAT1_HUMAN	Disease (Breast cancer)	---	A A/B	P	491 1491	A
25	UniProt	VAR_018265	L	600	P	STAT1_HUMAN	Disease (IMD31B)	137852678	A A/B	L	600 1600	P
26	UniProt	VAR_068713	K	637	E	STAT1_HUMAN	Disease (IMD31A)	587777705	A A/B	K	637 1637	E
27	UniProt	VAR_068714	K	673	R	STAT1_HUMAN	Disease (IMD31A)	587777704	A A/B	K	673 1673	R
	* ID not provided by source

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

PROSITE Motifs (1, 2)

Exons (20, 40)

Sequences/Alignments

Asymmetric Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:652
 aligned with STAT1_HUMAN | P42224 from UniProtKB/Swiss-Prot  Length:750

    Alignment length:682
                                    11        21        31        41        51        61        71        81        91       101       111       121       131       141       151       161       171       181       191       201       211       221       231       241       251       261       271       281       291       301       311       321       331       341       351       361       371       381       391       401       411       421       431       441       451       461       471       481       491       501       511       521       531       541       551       561       571       581       591       601       611       621       631       641       651       661       671       681  
         STAT1_HUMAN      2 SQWYELQQLDSKFLEQVHQLYDDSFPMEIRQYLAQWLEKQDWEHAANDVSFATIRFHDLLSQLDDQYSRFSLENNFLLQHNIRKSKRNLQDNFQEDPIQMSMIIYSCLKEERKILENAQRFNQAQSGNIQSTVMLDKQKELDSKVRNVKDKVMCIEHEIKSLEDLQDEYDFKCKTLQNREHETNGVAKSDQKQEQLLLKKMYLMLDNKRKEVVHKIIELLNVTELTQNALINDELVEWKRRQQSACIGGPPNACLDQLQNWFTIVAESLQQVRQQLKKLEELEQKYTYEHDPITKNKQVLWDRTFSLFQQLIQSSFVVERQPCMPTHPQRPLVLKTGVQFTVKLRLLVKLQELNYNLKVKVLFDKDVNERNTVKGFRKFNILGTHTKVMNMEESTNGSLAAEFRHLQLKEQKNAGTRTNEGPLIVTEELHSLSFETQLCQPGLVIDLETTSLPVVVISNVSQLPSGWASILWYNMLVAEPRNLSFFLTPPCARWAQLSEVLSWQFSSVTKRGLNVDQLNMLGEKLLGPNASPDGLIPWTRFCKENINDKNFPFWLWIESILELIKKHLLPLWNDGCIMGFISKERERALLKDQQPGTFLLRFSESSREGAITFTWVERSQNGGEPDFHAVEPYTKKELSAVTFPDIIRNYKVMAAENIPENPLKYLYPNIDKDHAFGKYYSR  683
               SCOP domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains 1yvlA01 A:2-126 Transcription Factor, Stat-4;                                                                                      1yvlA02 A:133-315  [code=1.20.1050.20, no name de      fined]                                                                                                                          1yvlA03 A:316-460  [code=2.60.40.630, no name defined]                                                                                           1yvlA04 A:461-581 EF-hand                                                                                                1yvlA05 A:582-683 SHC Adaptor Protein                                                                  CATH domains
               Pfam domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author hhhhhhh.....hhhhhhh......hhhhhhhhhhhhhhhhhhhhh.hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh.hhhhhhhhhhhhhhhhhhhhhh.hhhhhhh------hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh...------hhhhhh.hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh......hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh....hhhhhhhhhhhhhhhhhhhhhhhhheeeeeeee.........eee...eeeeeeee...hhhhh...eeeeee...............eee....eee.ee.......ee.eeeeeeeee...----------........eeeeeeeee..eeeeeeee....eee.hhhhhhhhhhhhhhhhhhh.............eehhhhhhhhhhhhhh.......hhhhhhhhhhhhhh........eehhhhhh-----...hhhhhhhhhhhhhhhhhhhhhhh.......hhhhhhhhhh......eeeee.......eeeeeeee...---..eeee...eehhhhh..hhhhhhhhh.ee.....ee..........hhhhhhhhhh.. Sec.struct. author
                 SAPs(SNPs) ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                    PROSITE -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------SH2  PDB: A:573-670 UniProt: 573-670                                                              ------------- PROSITE
           Transcript 1 (1) Exon 1.6  PDB: A:2-43 UniProt: 1-43       ------------------------------------------------Exon 1.8  PDB: A:92-124          Exon 1.9b UniProt: 125-154    Exon 1.10  PDB: A:155-181  ------------------------------Exon 1.12  PDB: A:212-262 UniProt: 212-262         ----------------------------------------------------Exon 1.14  PDB: A:315-346       -------------------Exon 1.16  -------------------------------Exon 1.18     Exon 1.19  PDB: A:425-449   Exon 1.20a  PDB: A:450-482       Exon 1.21  PDB: A:483-528 UniProt: 483-528    ----------------Exon 1.23  PDB: A:550-576       ------------------------------------------------Exon 1.25a  PDB: A:625-683 UniProt: 625-687 [INCOMPLETE]    Transcript 1 (1)
           Transcript 1 (2) -----------------------------------------Exon 1.7b  PDB: A:43-91 UniProt: 43-91           -----------------------------------------------------------------------------------------Exon 1.11  PDB: A:181-211 (gaps--------------------------------------------------Exon 1.13  PDB: A:262-315 UniProt: 262-315            ------------------------------Exon 1.15            ---------Exon 1.17  PDB: A:376-407       ------------------------------------------------------------------------------------------------------------------------Exon 1.22        -------------------------------Exon 1.24a  PDB: A:576-625 (gaps) UniProt: 576-625---------------------------------------------------------- Transcript 1 (2)
                1yvl A    2 SQWYELQQLDSKFLEQVHQLYDDSFPMEIRQYLAQWLEKQDWEHAANDVSFATIRFHDLLSQLDDQYSRFSLENNFLLQHNIRKSKRNLQDNFQEDPIQMSMIIYSCLKEERKILENAQRFNQAQ------TVMLDKQKELDSKVRNVKDKVMCIEHEIKSLEDLQDEYDFKCKTLQNRE------AKSDQKQEQLLLKKMYLMLDNKRKEVVHKIIELLNVTELTQNALINDELVEWKRRQQSACIGGPPNACLDQLQNWFTIVAESLQQVRQQLKKLEELEQKYTYEHDPITKNKQVLWDRTFSLFQQLIQSSFVVERQPCMPTHPQRPLVLKTGVQFTVKLRLLVKLQELNYNLKVKVLFDKDVNERNTVKGFRKFNILGTHTKVMNMEESTNGSLAAEFRHLQLKEQKN----------IVTEELHSLSFETQLCQPGLVIDLETTSLPVVVISNVSQLPSGWASILWYNMLVAEPRNLSFFLTPPCARWAQLSEVLSWQFSSVTKRGLNVDQLNMLGEKLLGPNASPDGLIPWTRFCK-----KNFPFWLWIESILELIKKHLLPLWNDGCIMGFISKERERALLKDQQPGTFLLRFSESSREGAITFTWVERSQ---EPDFHAVEPYTKKELSAVTFPDIIRNYKVMAAENIPENPLKYLYPNIDKDHAFGKYYSR  683
                                    11        21        31        41        51        61        71        81        91       101       111       121    |    - |     141       151       161       171       181      |191       201       211       221       231       241       251       261       271       281       291       301       311       321       331       341       351       361       371       381       391       401       411  |      -   |   431       441       451       461       471       481       491       501       511       521       531       541  |    551       561       571       581       591       601       611       621   |   631       641       651       661       671       681  
                                                                                                                                                      126    133                                             181    188                                                                                                                                                                                                                               414        425                                                                                                                    544   550                                                                    621 625

Chain B from PDB  Type:PROTEIN  Length:653
 aligned with STAT1_HUMAN | P42224 from UniProtKB/Swiss-Prot  Length:750

    Alignment length:682
                                    11        21        31        41        51        61        71        81        91       101       111       121       131       141       151       161       171       181       191       201       211       221       231       241       251       261       271       281       291       301       311       321       331       341       351       361       371       381       391       401       411       421       431       441       451       461       471       481       491       501       511       521       531       541       551       561       571       581       591       601       611       621       631       641       651       661       671       681  
         STAT1_HUMAN      2 SQWYELQQLDSKFLEQVHQLYDDSFPMEIRQYLAQWLEKQDWEHAANDVSFATIRFHDLLSQLDDQYSRFSLENNFLLQHNIRKSKRNLQDNFQEDPIQMSMIIYSCLKEERKILENAQRFNQAQSGNIQSTVMLDKQKELDSKVRNVKDKVMCIEHEIKSLEDLQDEYDFKCKTLQNREHETNGVAKSDQKQEQLLLKKMYLMLDNKRKEVVHKIIELLNVTELTQNALINDELVEWKRRQQSACIGGPPNACLDQLQNWFTIVAESLQQVRQQLKKLEELEQKYTYEHDPITKNKQVLWDRTFSLFQQLIQSSFVVERQPCMPTHPQRPLVLKTGVQFTVKLRLLVKLQELNYNLKVKVLFDKDVNERNTVKGFRKFNILGTHTKVMNMEESTNGSLAAEFRHLQLKEQKNAGTRTNEGPLIVTEELHSLSFETQLCQPGLVIDLETTSLPVVVISNVSQLPSGWASILWYNMLVAEPRNLSFFLTPPCARWAQLSEVLSWQFSSVTKRGLNVDQLNMLGEKLLGPNASPDGLIPWTRFCKENINDKNFPFWLWIESILELIKKHLLPLWNDGCIMGFISKERERALLKDQQPGTFLLRFSESSREGAITFTWVERSQNGGEPDFHAVEPYTKKELSAVTFPDIIRNYKVMAAENIPENPLKYLYPNIDKDHAFGKYYSR  683
               SCOP domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains 1yvlB01 B:1002-1123 Transcription Factor, Stat-4;                                                                                    1yvlB02 B:1135-1315  [code=1.20.1050.20, no name         defined]                                                                                                                    1yvlB03 B:1316-1460  [code=2.60.40.630, no name defined]                                                                                         1yvlB04 B:1461-1581 EF-hand                                                                                              1yvlB05 B:1582-1683 SHC Adaptor Protein                                                                CATH domains
           Pfam domains (1) STAT_int-1yvlB07 B:1002-1122                                                                                             -           -STAT_alpha-1yvlB05 B:1136-1315                                                                                                                                                      -STAT_bind-1yvlB01 B:1317-1567                                                                                                                                                                                                                              ---------SH2-1yvlB03 B:1577-1658                                                           ------------------------- Pfam domains (1)
           Pfam domains (2) STAT_int-1yvlB08 B:1002-1122                                                                                             -           -STAT_alpha-1yvlB06 B:1136-1315                                                                                                                                                      -STAT_bind-1yvlB02 B:1317-1567                                                                                                                                                                                                                              ---------SH2-1yvlB04 B:1577-1658                                                           ------------------------- Pfam domains (2)
         Sec.struct. author hhhhhhhh....hhhhhhh......hhhhhhhhhhhhhhhhhhhhh.hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh.hhhhhhhhhhhhhhhhhhhhhh.....-----------hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh....--------.........hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh......hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh....hhhhhhhhhhhhhhhhhhhhhhhhheeeeeeee.........eee....eeeeeee...hhhhh...eeeeee...............eee....eee.ee.......eeeeeeee.eee.---------...........eeeeeeeee..eeeeeeee....eee.hhhhhhhhhhhhhhhhhhh.............eehhhhhhhhhhhhhh.......hhhhhhhhhhhhh.........eehhhhhh........hhhhhhhhhhhhhhhhhhhhhhh.......hhhhhhhhh.......eeeee........eeeee....-.......ee....hhhhhh..hhhhhhhhh.ee.....ee..........hhhhhhhhhh.. Sec.struct. author
             SAPs(SNPs) (1) ----------------------------T--------------------------------------------------------------------------------------------------------------------------------------G----N---R----K---------------------NI----------------------------------------------------------------V---P--Q---E------RI-A---------N---------------------Q---------------------------------------------------------------DM-----------------------------------------------------------------------------H---------------------------A------------------------------------------------------------------------------------------------------------P------------------------------------E-----------------------------------R---------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) -------------------------------------------------------------------------------------------------------------------------------------------------------------------H------------------------------------V-----------------------------------------------------------------------W------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------A------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ SAPs(SNPs) (2)
                    PROSITE -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------SH2  PDB: B:1573-1670 UniProt: 573-670                                                            ------------- PROSITE
           Transcript 1 (1) Exon 1.6  PDB: B:1002-1043 UniProt: 1-43  ------------------------------------------------Exon 1.8  PDB: B:1092-1123       Exon 1.9b  PDB: B:1135-1154   Exon 1.10  PDB: B:1155-1181------------------------------Exon 1.12  PDB: B:1212-1262 UniProt: 212-262       ----------------------------------------------------Exon 1.14  PDB: B:1315-1346     -------------------Exon 1.16  -------------------------------Exon 1.18     Exon 1.19  PDB: B:1422-1449 Exon 1.20a  PDB: B:1450-1482     Exon 1.21  PDB: B:1483-1528 UniProt: 483-528  ----------------Exon 1.23  PDB: B:1545-1576     ------------------------------------------------Exon 1.25a  PDB: B:1625-1683 UniProt: 625-687 [INCOMPLETE]  Transcript 1 (1)
           Transcript 1 (2) -----------------------------------------Exon 1.7b  PDB: B:1043-1091 UniProt: 43-91       -----------------------------------------------------------------------------------------Exon 1.11 UniProt: 181-211     --------------------------------------------------Exon 1.13  PDB: B:1262-1315 UniProt: 262-315          ------------------------------Exon 1.15            ---------Exon 1.17  PDB: B:1376-1407     ------------------------------------------------------------------------------------------------------------------------Exon 1.22        -------------------------------Exon 1.24a  PDB: B:1576-1625 (gaps)               ---------------------------------------------------------- Transcript 1 (2)
                1yvl B 1002 SQWYELQQLDSKFLEQVHQLYDDSFPMEIRQYLAQWLEKQDWEHAANDVSFATIRFHDLLSQLDDQYSRFSLENNFLLQHNIRKSKRNLQDNFQEDPIQMSMIIYSCLKEERKILENAQRFN-----------MLDKQKELDSKVRNVKDKVMCIEHEIKSLEDLQDEYDFKCKTLQNREH--------DQKQEQLLLKKMYLMLDNKRKEVVHKIIELLNVTELTQNALINDELVEWKRRQQSACIGGPPNACLDQLQNWFTIVAESLQQVRQQLKKLEELEQKYTYEHDPITKNKQVLWDRTFSLFQQLIQSSFVVERQPCMPTHPQRPLVLKTGVQFTVKLRLLVKLQELNYNLKVKVLFDKDVNERNTVKGFRKFNILGTHTKVMNMEESTNGSLAAEFRHLQLKEQ---------GPLIVTEELHSLSFETQLCQPGLVIDLETTSLPVVVISNVSQLPSGWASILWYNMLVAEPRNLSFFLTPPCARWAQLSEVLSWQFSSVTKRGLNVDQLNMLGEKLLGPNASPDGLIPWTRFCKENINDKNFPFWLWIESILELIKKHLLPLWNDGCIMGFISKERERALLKDQQPGTFLLRFSESSREGAITFTWVERS-NGGEPDFHAVEPYTKKELSAVTFPDIIRNYKVMAAENIPENPLKYLYPNIDKDHAFGKYYSR 1683
                                  1011      1021      1031      1041      1051      1061      1071      1081      1091      1101      1111      1121 |       -   |  1141      1151      1161      1171      1181|     1191      1201      1211      1221      1231      1241      1251      1261      1271      1281      1291      1301      1311      1321      1331      1341      1351      1361      1371      1381      1391      1401      1411|        -|     1431      1441      1451      1461      1471      1481      1491      1501      1511      1521      1531      1541      1551      1561      1571      1581      1591      1601      1611        |-|     1631      1641      1651      1661      1671      1681  
                                                                                                                                                  1123        1135                                           1182     1191                                                                                                                                                                                                                         1412      1422                                                                                                                                                                                                  1620 |                                                             
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     1622

Chain C from PDB  Type:PROTEIN  Length:5
                                      
               SCOP domains ----- SCOP domains
               CATH domains ----- CATH domains
               Pfam domains ----- Pfam domains
         Sec.struct. author ..... Sec.struct. author
                 SAPs(SNPs) ----- SAPs(SNPs)
                    PROSITE ----- PROSITE
                 Transcript ----- Transcript
                1yvl C  440 yDKPH  444
                            |    
                          440-PTR

Chain D from PDB  Type:PROTEIN  Length:5
                                      
               SCOP domains ----- SCOP domains
               CATH domains ----- CATH domains
               Pfam domains ----- Pfam domains
         Sec.struct. author ..... Sec.struct. author
                 SAPs(SNPs) ----- SAPs(SNPs)
                    PROSITE ----- PROSITE
                 Transcript ----- Transcript
                1yvl D 1440 yDKPH 1444
                            |    
                            |    
                         1440-PTR

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Classification and Annotation

SCOP Domains (0, 0)

CATH Domains (5, 10)

Pfam Domains (4, 8)

Gene Ontology (58, 58)

Asymmetric Unit(hide GO term definitions)

Chain A,B (STAT1_HUMAN | P42224)

molecular function
	GO:0003677	DNA binding	Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
	GO:0000978	RNA polymerase II core promoter proximal region sequence-specific DNA binding	Interacting selectively and non-covalently with a sequence of DNA that is in cis with and relatively close to a core promoter for RNA polymerase II.
	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	Interacting selectively and non-covalently with the regulatory region composed of the transcription start site and binding sites for transcription factors of the RNA polymerase II basal transcription machinery.
	GO:0003690	double-stranded DNA binding	Interacting selectively and non-covalently with double-stranded DNA.
	GO:0019899	enzyme binding	Interacting selectively and non-covalently with any enzyme.
	GO:0042802	identical protein binding	Interacting selectively and non-covalently with an identical protein or proteins.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0042803	protein homodimerization activity	Interacting selectively and non-covalently with an identical protein to form a homodimer.
	GO:0004871	signal transducer activity	Conveys a signal across a cell to trigger a change in cell function or state. A signal is a physical entity or change in state that is used to transfer information in order to trigger a response.
	GO:0000983	transcription factor activity, RNA polymerase II core promoter sequence-specific	Interacting selectively and non-covalently with a specific DNA sequence in an RNA polymerase II (Pol II) core promoter, the region composed of the transcription start site and binding sites for transcription factors of the Pol II basal transcription machinery, in order to modulate transcription by Pol II. The transcription factor may or may not also interact selectively with a protein or macromolecular complex.
	GO:0003700	transcription factor activity, sequence-specific DNA binding	Interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription. The transcription factor may or may not also interact selectively with a protein or macromolecular complex.
	GO:0005164	tumor necrosis factor receptor binding	Interacting selectively and non-covalently with the tumor necrosis factor receptor.
biological process
	GO:0007259	JAK-STAT cascade	Any process in which STAT proteins (Signal Transducers and Activators of Transcription) and JAK (Janus Activated Kinase) proteins convey a signal to trigger a change in the activity or state of a cell. The JAK-STAT cascade begins with activation of STAT proteins by members of the JAK family of tyrosine kinases, proceeds through dimerization and subsequent nuclear translocation of STAT proteins, and ends with regulation of target gene expression by STAT proteins.
	GO:0006915	apoptotic process	A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
	GO:0008015	blood circulation	The flow of blood through the body of an animal, enabling the transport of nutrients to the tissues and the removal of waste products.
	GO:0071345	cellular response to cytokine stimulus	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus.
	GO:0035458	cellular response to interferon-beta	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-beta stimulus. Interferon-beta is a type I interferon.
	GO:0071407	cellular response to organic cyclic compound	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
	GO:0051607	defense response to virus	Reactions triggered in response to the presence of a virus that act to protect the cell or organism.
	GO:0043542	endothelial cell migration	The orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
	GO:0060333	interferon-gamma-mediated signaling pathway	A series of molecular signals initiated by the binding of interferon-gamma to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Interferon gamma is the only member of the type II interferon found so far.
	GO:0072162	metanephric mesenchymal cell differentiation	The process in which relatively unspecialized cells acquire specialized structural and/or functional features that characterize the mesenchymal cells of the metanephros as it progresses from its formation to the mature state.
	GO:0072136	metanephric mesenchymal cell proliferation involved in metanephros development	The multiplication or reproduction of cells, resulting in the expansion of a metanephric mesenchymal cell population.
	GO:0046725	negative regulation by virus of viral protein levels in host cell	Any process where the infecting virus reduces the levels of viral proteins in a cell.
	GO:0043124	negative regulation of I-kappaB kinase/NF-kappaB signaling	Any process that stops, prevents, or reduces the frequency, rate or extent of -kappaB kinase/NF-kappaB signaling.
	GO:0016525	negative regulation of angiogenesis	Any process that stops, prevents, or reduces the frequency, rate or extent of angiogenesis.
	GO:0001937	negative regulation of endothelial cell proliferation	Any process that stops, prevents, or reduces the rate or extent of endothelial cell proliferation.
	GO:0003340	negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis	Any process that decreases the rate, frequency or extent of the transition where a mesenchymal cell establishes apical/basolateral polarity,forms intercellular adhesive junctions, synthesizes basement membrane components and becomes an epithelial cell that will contribute to the shaping of the metanephros.
	GO:0072308	negative regulation of metanephric nephron tubule epithelial cell differentiation	Any process that decreases the frequency, rate or extent of metanephric nephron tubule epithelial cell differentiation.
	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter.
	GO:0002053	positive regulation of mesenchymal cell proliferation	The process of activating or increasing the rate or extent of mesenchymal cell proliferation. Mesenchymal cells are loosely organized embryonic cells.
	GO:0048661	positive regulation of smooth muscle cell proliferation	Any process that activates or increases the rate or extent of smooth muscle cell proliferation.
	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
	GO:0045893	positive regulation of transcription, DNA-templated	Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
	GO:0042981	regulation of apoptotic process	Any process that modulates the occurrence or rate of cell death by apoptotic process.
	GO:0060334	regulation of interferon-gamma-mediated signaling pathway	Any process that modulates the rate, frequency or extent of the series of molecular events generated as a consequence of interferon-gamma binding to a cell surface receptor.
	GO:0006357	regulation of transcription from RNA polymerase II promoter	Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter.
	GO:0006355	regulation of transcription, DNA-templated	Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
	GO:0060338	regulation of type I interferon-mediated signaling pathway	Any process that modulates the rate, frequency or extent of a type I interferon-mediated signaling pathway. A type I interferon-mediated signaling pathway is the series of molecular events generated as a consequence of a type I interferon binding to a cell surface receptor.
	GO:0061326	renal tubule development	The progression of the renal tubule over time from its formation to the mature form. A renal tubule is a tube that filters, re-absorbs and secretes substances to rid an organism of waste and to play a role in fluid homeostasis.
	GO:0051591	response to cAMP	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus.
	GO:0034097	response to cytokine	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus.
	GO:0035456	response to interferon-beta	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-beta stimulus. Interferon-beta is a type I interferon.
	GO:0043434	response to peptide hormone	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptide hormone stimulus. A peptide hormone is any of a class of peptides that are secreted into the blood stream and have endocrine functions in living animals.
	GO:0007165	signal transduction	The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
	GO:0006351	transcription, DNA-templated	The cellular synthesis of RNA on a template of DNA.
	GO:0033209	tumor necrosis factor-mediated signaling pathway	A series of molecular signals initiated by the binding of a tumor necrosis factor to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
	GO:0060337	type I interferon signaling pathway	A series of molecular signals initiated by the binding of a type I interferon to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.
	GO:0016032	viral process	A multi-organism process in which a virus is a participant. The other participant is the host. Includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle.
cellular component
	GO:0030424	axon	The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter.
	GO:0005737	cytoplasm	All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
	GO:0005829	cytosol	The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
	GO:0030425	dendrite	A neuron projection that has a short, tapering, often branched, morphology, receives and integrates signals from other neurons or from sensory stimuli, and conducts a nerve impulse towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body.
	GO:0000790	nuclear chromatin	The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome in the nucleus.
	GO:0005730	nucleolus	A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome.
	GO:0005654	nucleoplasm	That part of the nuclear content other than the chromosomes or the nucleolus.
	GO:0005634	nucleus	A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
	GO:0048471	perinuclear region of cytoplasm	Cytoplasm situated near, or occurring around, the nucleus.

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (2, 4)

Sites (2, 2)

SS Bonds (0, 0)

Cis Peptide Bonds (0, 0)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (27, 54)

PROSITE Motifs (1, 2)

Exons (20, 40)

Sequences/Alignments

Classification and Annotation

SCOP Domains (0, 0)

CATH Domains (5, 10)

Pfam Domains (4, 8)

Gene Ontology (58, 58)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File